| Objective: To investigate the clinical effect of thunder fire moxibustion on Wuzang Beiyu point on cancer-related fatigue in patients with non-small cell lung cancer (NSCLC) of qi deficiency type after chemotherapy. Methods: 93 patients with NSCLC who were admitted to our hospital from March 2020 to May 2022 were selected, and they were divided into the control group (n=46, receiving conventional treatment) and the observation group (n=47, receiving thunder fire moxibustion on Wuzang Beiyu point on the basis of the control group) by random number table method. The Brief Fatigue Inventory (BFI) score, traditional Chinese medicine syndrome score, hemorheology index, T lymphocyte subsets index and quality of life score were compared in the two groups. Results: The BFI score in the observation group at 7d after treatment and 14d after treatment were lower than those in the control group in the same period (P<0.05). The scores of abdominal distension and drowsiness, chest tightness and shortness of breath, fatigued spirit and lack of strength, cough and phlegm for a long time , and dropsy and loose stool in the observation group at 7d after treatment were lower than those in the control group at the same period (P<0.05). The high shear whole blood viscosity, low shear whole blood viscosity, hematocrit, and plasma viscosity in the observation group at 14d after treatment were lower than those in the control group at the same period (P<0.05). CD8+ in the observation group at 14d after treatment was lower than that in the control group at the same period, and CD3+, CD4+, and CD4+/CD8+ were higher than those in the control group at the same period (P<0.05). The scores of functional, additional symptoms of lung cancer, physiological, social/family, and emotional in the observation group were higher than those in the control group at the same period (P<0.05). Conclusion: Thunder fire moxibustion on Wuzang Beiyu point can effectively reduce the symptoms of cancer-related fatigue in patients with NSCLC of qi deficiency type after chemotherapy, regulate the level of hemorheology and immune function, and improve the quality of life of patients. |
